title: Targeting sphingosine kinase 1 in cancer.
authors.affiliation: Cell Biology Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK. n.j.pyne@strath.ac.uk
authors.forename: Nigel J
authors.initials: NJ
authors.lastname: Pyne
authors.forename: Francesca
authors.initials: F
authors.lastname: Tonelli
authors.forename: Keng Gat
authors.initials: KG
authors.lastname: Lim
authors.forename: Jaclyn
authors.initials: J
authors.lastname: Long
authors.forename: Joanne
authors.initials: J
authors.lastname: Edwards
authors.forename: Susan
authors.initials: S
authors.lastname: Pyne
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000099157:Sphingosine Kinase
chemical_list: D000970:Antineoplastic Agents; D017853:Phosphotransferases (Alcohol Group Acceptor); D000099157:Sphingosine Kinase